Skip to main content

Table 3 Correlation between TGFB1 and TGFBR2 SNPs TGFβ1 components staining

From: TGFβ1 pathway components in breast cancer tissue from aggressive subtypes correlate with better prognostic parameters in ER-positive and p53-negative cancers

Variant

Modela

Correlation with genetic variant [Tau-c (p)]

TGFβ1

TGFβRII

p-SMAD2/3

TGFBR2 G-875A (rs3087465)

Additive

−0.127 (0.456)

−0.138 (0.399)

−0.151 (0.327)

Dominant

−0.183 (0.357)

− 0.211 (0.279)

− 0.194 (0.321)

Recessive

0.021 (0.877)

0.042 (0.733)

−0.028 (0.787)

TGFB1 G-800A (rs1800468)

Dominant

0.066 (0.549)

0.107 (0.301)

0.031 (0.684)

TGFB1 C-509T (rs1800469)

Additive

0031 (0.820)

0.005 (0.971)

0.013 (0.927)

Dominant

−0.028 (0.802)

− 0.007 (0.955)

− 0.010 (0.930)

Recessive

0.055 (0.765)

0.014 (0.940)

0.035 (0.851)

TGFB1 T29C (rs1800470)

Additive

−0.096 (0517)

−0.153 (0.300)

− 0.093 (0.513)

Dominant

−0.121 (0.289)

−0.183 (0.121)

− 0.128 (0.231)

Recessive

−0.066 (0.737)

−0.093 (0.627)

− 0.028 (0.886)

TGFB1 G74C (rs1800471)

Additive

−0.026 (0.792)

−0.067 (0.513)

− 0.057 (0.552)

Dominant

−0.048 (0.727)

−0.104 (0.480)

− 0.090 (0.514)

Recessive

0.055 (0.334)

0.021 (0.714)

0.000 (1.000)

TGFB1 GCTG haplotype

Additive

−0.075 (0.596)

−0.039 (0.787)

0.000 (1.000)

Dominant

−0.104 (0.606)

−0.090 (0.651)

− 0.038 (0.849)

Recessive

0.003 (0.959)

0.059 (0.459)

0.073 (0.364)

TGFB1 GTCG haplotype

Additive

−0.096 (0.477)

−0.127 (0.359)

− 0.062 (0.662)

Dominant

−0.145 (0.300)

−0.131 (0.372)

− 0.066 (0.637)

Recessive

−0.045 (0.790)

−0.087 (0.602)

− 0.031 (0.861)

  1. aAdditive model: wild homozygotes = 0, heterozygotes = 1; variant homozygotes = 2; Dominant model: wild homozygotes = 0, heterozygotes and variant homozygotes = 1; Recessive model: wild homozygotes and heterozygotes = 0, variant homozygotes = 1